IDH2 and glioma: When categorized into two groups according to the median score, we observed a better overall survival in glioma with high SSTR2 mRNA expression (p = 0.056) among the low grade glioma IDH-mutant and 1p/19q-codeleted subgroup (Fig. 5b).